Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking strategy to diabetes management. These innovative therapies operate by mimicking the physiological actions of GLP-1, a hormone produced https://sociallweb.com/story6299687/the-emerging-role-of-glp-1-receptor-agonists-in-diabetes-management